Ranbaxy settles violation dispute

December 21, 2011 13:09

Ranbaxy Laboratories of India agreed to a settlement with the United States Food and Drug Administration and will make a $500 million provision in relation to a Justice Department investigation to resolve a dispute about plant violations. More on the NYT.

« Back to LIVE

TOP STORIES

Police suspect Bangla MP honey-trapped before murder; 1 detained

The initial probe into the murder of Bangladesh MP Anwarul Azim Anar revealed that one of his friends had paid around Rs 5 crore to kill the neighbouring country's parliamentarian, a senior police officer said here on Thursday.

Pune car crash: Police quiz teen's grandfather; driver may be made witness

The officer said that the driver may be presented in the court as a witness in the case.

Phase VI: 58 LS seats, including all 7 in Delhi, to vote on Saturday

Besides the national capital, polling for the sixth round of the marathon seven-phase elections will be held Saturday in 14 seats in Uttar Pradesh, all 10 seats of Haryana, eight seats each in Bihar and West Bengal, six seats in Odisha,...

Panghal in focus as Indian boxers fight in final qualifiers for Paris

Indian pugilists will be determined to overcome the recent setbacks both inside and outside the boxing ring when they aim for the last available tickets to the Olympic Games at the second World Qualification Tournament, starting in...

Dombivli chemical factory blast toll rises to 8; more than 60 injured

A major fire broke out inside the industrial area of Dombivli in Thane after a boiler exploded at the plant of a chemical company.